Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 118, Issue 2, 2005, Pages 229-234

  Hernádi, Zoltán ^a   Szoke, Krisztina ^a   Sápy, Tamás ^a   Krasznai, Zoárd T ^a   Soós, Györgyike ^a   Veress, György ^a   Gergely, Lajos ^a,b   Kónya, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

HPV screening; Recurrence of CIN, Post treatment HPV infection

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CERVICAL PRECANCER; CERVICALIS INTRAEPITHELIALIS NEOPLASIA; CONTROLLED STUDY; CYTOLOGY; DATA ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRECANCER; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; UTERUS SURGERY; VERRUCA VULGARIS; VIRUS IDENTIFICATION; WART VIRUS;

EID: 11844286255     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.06.029     Document Type: Article

References (28)

1. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, and P. Palan Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst. 87 1995 1365 1371
2. M.A. Nobbenhuis, J.M. Walboomers, T.J. Helmerhorst, L. Rozendaal, A.J. Remmink, and E.K. Risse Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study Lancet. 354 1999 20 25
3. K.L. Wallin, F. Wiklund, T. Angstrom, F. Bergman, U. Stendahl, and G. Wadell Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer N Engl J Med. 341 1999 1633 1638
4. M. Evander, K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, and E. Rylander Human papillomavirus infection is transient in young women: a population-based cohort study J Infect Dis. 171 1995 1026 1030
5. A. Hildesheim, M.H. Schiffman, P.E. Gravitt, A.G. Glass, C.E. Greer, and T. Zhang Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis. 169 1994 235 240
6. L. Kjellberg, F. Wiklund, I. Sjoberg, G. Wadell, T. Angstrom, and J. Dillner A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia Am J Obstet Gynecol. 179 1998 1497 1502
7. M.M. Manos, W.K. Kinney, L.B. Hurley, M.E. Sherman, J. Shieh Ngai, and R.J. Kurman Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results J Am Med Assoc 281 1999 1605 1610
8. J.T. Cox, A.T. Lorincz, M.H. Schiffman, M.E. Sherman, A. Cullen, and R.J. Kurman Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance Am J Obstet Gynecol. 172 1995 946 954
9. J. Cuzick, P. Sasieni, P. Davies, J. Adams, C. Normand, and A. Frater A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions Br J Cancer. 83 2000 561 565
10. S. Ratnam, E. Franco, and A. Ferenczy Human papillomavirus testing for primary screening of cervical cancer precursors Cancer Epidemiol Biomarkers Prev. 9 2000 945 951
11. J. Dillner Primary screening for human papillomavirus infection Best Pract Res Clin Obstet Gynaecol. 15 2001 743 757
12. O. Reich, H. Pickel, M. Lahousen, K. Tamussino, and R. Winter Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins Obstet Gynecol. 97 2001 428 430
13. F.E. Skjeldestad, B. Hagen, A.K. Lie, and C. Isaksen Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia Obstet Gynecol. 90 1997 428 433
14. S.P. Dobbs, T. Asmussen, D. Nunns, J. Hollingworth, L.J. Brown, and D. Ireland Does histological incomplete excision of cervical intraepithelial neoplasia following large loop excision of transformation zone increase recurrence rates? A six-year cytological follow up. Br J Obstet Gynaecol 107 2000 1298 1301
15. G. Nuovo, J. Moritz, A. Kowalik, E. Chalas, B. Kaplan, and W. Mann Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization Gynecol Oncol. 46 1992 304 308
16. J.E. Tate, M. Resnick, E.E. Sheets, and C.P. Crum Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasms Obstet Gynecol. 88 1996 257 260
17. S. Costa, P. De Simone, S. Venturoli, M. Cricca, M.L. Zerbini, and M. Musiani Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization Gyn Oncol. 90 2003 358 365
18. K. Elfgren, P. Bistoletti, L. Dillner, J.M. Walboomers, C.J. Meijer, and J. Dillner Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens Am J Obstet Gynecol. 174 1996 937 942
19. L. Kjellberg, G. Wadell, F. Bergman, M. Isaksson, T. Angstrom, and J. Dillner Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser Am J Obstet Gynecol. 183 2000 1238 1242
20. K.L. Chua, and A. Hjerpe Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri Gynecol Oncol. 66 1997 108 113
21. M. Nobbenhuis, C. Meijer, A. van den Brule, L. Rozendaal, F. Voorhorst, and E. Risse Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia Br J Cancer. 84 2001 796 801
22. A. Stafl, and G.D. Wilbanks An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy Obstet Gynaecol. 77 1991 313 314
23. R.J. Kurman, and D. Solomon The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Definitions, criteria, and explanatory notes for terminology and specimen adequacy 1994 Springer Verlag New York pp. 1-267
24. K. Szoke, T. Sápy, Z. Krasznai, Z. Hernádi, Gy. Szládek, and J. Veress Moderate variation of the oncogenic potential among high-risk human papilloma virus types in gynecologic patients with cervical abnormalities J. Med. Virol. 71 2003 585 592
25. J. Kónya, G. Veress, A. Juhász, K. Szarka, T. Sápy, and Z. Hernádi Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia J Clin Microbiol. 38 2000 408 411
26. L. Rozsa, J. Reiczigel, and G. Majoros Quantifying parasites in samples of hosts J Parasitol. 86 2000 228 232
27. L.J. Bollen, A.P. Tjong, J. van der Velden, B.W. Mol, F.W. ten Kate, and J. ter Schegget Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology Gynecol Oncol. 72 1999 199 201
28. Y. Nagai, T. Maehama, T. Asato, and K. Kanazawa Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol. 79 2000 294 299